NCT01769521

Brief Summary

Interplay between the increasing IOP and decreasing blood pressure (BP) during the 24-hour period, especially in the nocturnal period, may lead to insufficient perfusion pressure of the optic nerve and contribute to the glaucomatous damage in adjunct to the antero-posterior vectorial mechanical impact on the lamina cribrosa, the translaminar pressure. Patients with progressive VF loss showed greater nocturnal BP dips than patients with stable VF. Reduced mean intraocular perfusion pressure (IOPP) was significantly associated with the extent of glaucomatous damage. How the nycthemeral IOP fluctuation influences glaucoma progression has not been studied in a prospective manner and remains to be elucidated. The purpose of this study is to assess the relationship between the 24-hour IOP fluctuation pattern and the 24-hour BP pattern in patients with primary open angle glaucoma (POAG). IOP fluctuations will be monitored with SENSIMED Triggerfish®, a portable investigational device using a contact lens sensor that monitors the IOP fluctuation continuously over 24-hours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 16, 2013

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

November 17, 2015

Status Verified

November 1, 2015

Enrollment Period

6 months

First QC Date

January 10, 2013

Last Update Submit

November 16, 2015

Conditions

Keywords

GlaucomaIOPBlood pressureECG

Outcome Measures

Primary Outcomes (1)

  • To evaluate the relationship between the 24-hour IOP fluctuations as monitored by Triggerfish® and the 24-hour blood pressure pattern in patients with POAG.

    24-hour

Secondary Outcomes (5)

  • Nycthemeral IOP pattern

    24-hour

  • Relationship between the nocturnal IOP fluctuation pattern and the diurnal fluctuation pattern (office hours)

    24 hours

  • Relationship between intraocular pulsation amplitude and BP

    24-hours

  • Relationship between the intraocular pulsation frequency and heart rate (HR)

    24-hours

  • Assess safety and tolerability

    24-hours

Study Arms (1)

Triggerfish

EXPERIMENTAL

Device: Sensimed Triggerfish

Device: Sensimed Triggerfish®

Interventions

Portable investigational device using a contact lens sensor that monitors the IOP fluctuation continuously over 24-hours

Triggerfish

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of POAG, including progressing normal tension glaucoma (NTG) based on recent or recurrent disc haemorrhage
  • No anti-glaucomatous drug treatment or washed-out for a period of 4 weeks prior to SD0 and absent throughout the study
  • Aged more than 18 years, of either sex
  • Not more than 4 diopters spherical equivalent on both eyes
  • Not more than 2 diopters cylinder equivalent on both eyes
  • Have given written informed consent, prior to pre-study screening

You may not qualify if:

  • Patients with history of ocular surgery within the last 3 months
  • Corneal or conjunctival abnormality hindering contact lens adaptation
  • Severe dry eye
  • Secondary forms of OAG
  • Patients with systemic hypertension
  • Patients with allergy to corneal anesthetic
  • Patients with contraindications for silicone contact lens wear
  • Wear of full frame metallic glasses during Triggerfish® monitoring
  • Patients not able to understand the character and individual consequences of the investigation
  • Simultaneous participation in other clinical research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Przemienienia Pańskiego Hospital, Poznan University of Medical Sciences Karol Marcinkowski

Poznan, 61-848, Poland

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleLow Tension GlaucomaGlaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesOptic Nerve Diseases

Study Officials

  • Jarosław Kocięcki, MD

    Przemienienia Pańskiego Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2013

First Posted

January 16, 2013

Study Start

October 1, 2012

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

November 17, 2015

Record last verified: 2015-11

Locations